Skip to main content
. 2007 May 18;73(13):4234–4242. doi: 10.1128/AEM.00509-07

TABLE 2.

Oligonucleotides used in this study

Designation Sequencea
SifA-Red-Luc-For 5′-ATTATGTAGTCATTTTTACTCCAGTATAAGTGAGATTAATATGGAAGACGCCAAAAACATAA-3′
SifA-Red-LacZ-For 5′-CAGTATAAGTGAGATTAATATGCCGATTACTATAGGGAATCCCGTCGTTTTACAACGTCG-3′
SifA-Red-Rep-Rev 5′-ACCCTGAACGTGACGTCTGAGAAAGCGTCGTCTGATTTTAGTGTAGGCTGGAGCTGCTTC-3′
SseJ200-Red-Luc-For 5′-TTTATCATCTCCACACTTCTTAGGTAAAGAGATGCTTAATGAAGACGCCAAAAACATAA-3′
SseJ-Red-GFPm-For 5′-TTTGCTAAAGCGTGTTTAATAAAGTAAGGAGGACACTATGAGTAAAGGAGAAGAACTTTTC-3′
SseJ-Red-LacZ-For 5′-TTAATAAAGTAAGGAGGACACTATGCCATTGAGTGTTGGACCCGTCGTTTTACAACGTCG-3′
SseJ-Red-Rep-Rev 5′-CGGCACTATGATATTGAGCTGTGTTTTGCTCAAGGCGTACGTGTAGGCTGGAGCTGCTTC-3′
SopE2-Red-Luc-For 5′-TATAGAAAATATTGCGAATAAGTATCTTCAGAATGCCTCCGAAGACGCCAAAAACATAA-3′
SopE2-Red-Rep-Rev 5′-GGCAAACCAGCGCCAATGCAGGTGTCGTTACCGTGGCGACCCGTGTAGGCTGGAGCTGCTTC-3′
MgtA-Red-LacZ-For 5′-TGACTTCGGCGCGGAGGGATTACCTATGCTAAAAATCATTCCCGTCGTTTTACAACGTCG-3′
MgtA-Red-Luc-For 5′-GAATTTTCTGCGCCTGACTTCGGCGCGGAGGGATTACCTATGGAAGACGCCAAAAACATA-3′
MgtA-Red-Rep-Rev 5′-TTAAGCACGCTGGCGAATCCCCGACGAAAGTGTTTACTGCGTGTAGGCTGGAGCTGCTTC-3′
EC-MgtA-Red-LacZ-For 5′-TTCAGACAGTGCGGAGGGACTCCTTATGTTTAAAGAAATTCCCGTCGTTTTACAACGTCG-3′
EC-MgtA-Red-Luc-For 5′-CATTTCTGTACTGTTTCAGACAGTGCGGAGGGACTCCTTATGGAAGACGCCAAAAACATA-3′
EC-MgtA-Red-Rep-Rev 5′-GCCGTAACGACGGCTATAGAACCCTTTCACCAACTGGGTCGTGTAGGCTGGAGCTGCTTC-3′
GyrA-Red-SDo-Luc-For 5′-GGAAAGCGATGACGACGTTGCGGATGACGCTGACGAGTAAAAACTGGAGACTGTCATGGAAGACGCCAAAAACAT-3′
GyrA-Red-Rep-Rev 5′-AAAGAAAAAGGGCCGGATATCCGGCCCTCGCACAGCAATACGTGTAGGCTGGAGCTGCTTC-3′
Luc-Red-Check-For 5′-GAGGAGTTGTGTTTGTGGAC-3′
Luc-Red-Check-Rev 5′-AGTAGTGACAAGTGTTGGCC-3′
GFP-Red-Check-For 5′-CAGACAACCATTACCTGTCC-3′
GFP-Red-Check-Rev 5′-AGGTAGTTTTCCAGTAGTGC-3′
LacZ-Red-Check-Rev 5′-TGTGAGCGAGTAACAACCCG-3′
a

Nucleotides complementary to the template plasmids are set in italics, and the portion containing the RBS is underlined.

HHS Vulnerability Disclosure